Cardiorespiratory fitness: an independent and additive marker of risk stratification and health outcomes.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 2735426)

Published in Mayo Clin Proc on September 01, 2009

Authors

Barry A Franklin, Peter A McCullough

Articles cited by this

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32

Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA (1989) 14.34

Exercise capacity and mortality among men referred for exercise testing. N Engl J Med (2002) 14.30

Using pedometers to increase physical activity and improve health: a systematic review. JAMA (2007) 10.04

Exercise and cardiovascular risk reduction: time to update the rationale for exercise? J Appl Physiol (1985) (2008) 8.17

Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA (1996) 7.45

A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24

Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA (1995) 7.14

Physical activity and the incidence of coronary heart disease. Annu Rev Public Health (1987) 6.76

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation (2007) 4.97

Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA (1999) 4.90

Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation (2003) 4.19

Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc (2001) 3.74

Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med (2000) 3.66

Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol (2003) 1.49

Effects of physical activity on insulin action and glucose tolerance in obesity. Med Sci Sports Exerc (1999) 1.38

Cardiovascular fitness as a predictor of mortality in men. Arch Intern Med (2001) 1.32

The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc (2009) 1.08

Cardiorespiratory fitness and sedentary lifestyle in the morbidly obese. Clin Cardiol (2009) 1.00

Comparison of left ventricular ejection fraction and exercise capacity as predictors of two- and five-year mortality following acute myocardial infarction. Am J Cardiol (2006) 0.93

Usefulness of cardiorespiratory fitness as a predictor of all-cause and cardiovascular disease mortality in men with systemic hypertension. Am J Cardiol (2001) 0.92

Articles by these authors

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc (2007) 20.11

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc (2011) 14.42

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94

Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med (2013) 7.29

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension (2003) 6.01

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Circulation (2008) 4.62

American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc (2004) 4.48

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90

Physical activity intervention studies: what we know and what we need to know: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); Council on Cardiovascular Disease in the Young; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation (2006) 3.72

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 3.55

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 3.48

Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26

Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA (2008) 3.12

Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation (2007) 3.11

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev (2006) 2.99

Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation (2005) 2.81

Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation (2010) 2.76

Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74

American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation (2003) 2.49

Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation (2007) 2.49

AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol (2011) 2.45

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol (2006) 2.41

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol (2003) 2.34

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol (2005) 2.31

Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24

Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med (2004) 2.23

Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18

Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise. Am J Cardiol (2005) 2.15

Counseling for physical activity in overweight and obese patients. Am Fam Physician (2003) 2.13

Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08

Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation (2011) 2.05

Blood B-type natriuretic peptide and dialysis: present assessment and future analyses. South Med J (2008) 2.03

Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc (2012) 1.98

Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol (2008) 1.97

Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J (2007) 1.93

Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol (2012) 1.90

Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail (2008) 1.89

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88

Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol (2005) 1.84

Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Circulation (2004) 1.81

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 1.80

Physical activity and exercise recommendations for stroke survivors: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 1.77

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv (2013) 1.74

Pathophysiology of contrast-induced nephropathy. Am J Cardiol (2006) 1.73

Baseline renal function screening. Am J Cardiol (2006) 1.72

Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71

Physical activity and exercise recommendations for stroke survivors: an American Heart Association scientific statement from the Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention; the Council on Cardiovascular Nursing; the Council on Nutrition, Physical Activity, and Metabolism; and the Stroke Council. Stroke (2004) 1.71

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail (2004) 1.66

American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation (2013) 1.66

Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol (2003) 1.64

Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study. Ann Emerg Med (2005) 1.63

Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol (2005) 1.62

Behavioral predictors of weight regain after bariatric surgery. Obes Surg (2009) 1.60

Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation (2011) 1.59

Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia. Am J Cardiol (2004) 1.59

The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail (2005) 1.58

Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients. Chest (2008) 1.54

Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. J Am Coll Cardiol (2010) 1.53

Validity of estimated glomerular filtration rates for assessment of baseline and serial renal function in patients with atherosclerotic renal artery stenosis: implications for clinical trials of renal revascularization. Circ Cardiovasc Interv (2011) 1.53

Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis (2009) 1.52

Comparative impact of morbid obesity vs heart failure on cardiorespiratory fitness. Chest (2005) 1.52

Hemostatic responses to resistance training in patients with coronary artery disease. J Cardiopulm Rehabil (2006) 1.48

Outcomes of patients considered for, but not admitted to, the intensive care unit. Crit Care Med (2008) 1.48

Failure of beta-blockers in the reduction of perioperative events: where did we go wrong? Am Heart J (2006) 1.46

Impact of obesity on cardiovascular disease. Med Clin North Am (2011) 1.44

Lessons learned from the COURAGE trial: generalizability, limitations, and implications. Prev Cardiol (2007) 1.42

Spouses' provision of health-related support and control to patients participating in cardiac rehabilitation. J Fam Psychol (2006) 1.42

Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation (2004) 1.42

Worksite wellness programs for cardiovascular disease prevention: a policy statement from the American Heart Association. Circulation (2009) 1.41

Improved noninvasive coronary angiography in morbidly obese patients with dual-source computed tomography. J Cardiovasc Comput Tomogr (2008) 1.41

Determinants of markedly increased B-type natriuretic peptide in patients with ST-segment elevation myocardial infarction. Am J Emerg Med (2010) 1.39

No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney Int (2013) 1.38

Cardiovascular emergency preparedness in recreation facilities at major US universities: college fitness center emergency readiness. Prev Cardiol (2007) 1.38

The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation (2013) 1.37

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA (2003) 1.36

Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. Am J Kidney Dis (2008) 1.36

Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D). Clin J Am Soc Nephrol (2008) 1.36

Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med (2012) 1.34

Acute cardiac effects of marathon running. J Appl Physiol (1985) (2010) 1.32

Effectiveness of three models for comprehensive cardiovascular disease risk reduction. Am J Cardiol (2002) 1.32

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J (2004) 1.31

Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2013) 1.29

Congestive heart failure and QRS duration: establishing prognosis study. Chest (2002) 1.28

The power of play: Innovations in Getting Active Summit 2011: a science panel proceedings report from the American Heart Association. Circulation (2011) 1.28

CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.26